CoChat

Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

An exploration of the influence of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma. This was a quasi-experimental study. During March 2019 to March 2020, 96 patients with metastatic colorectal carcinoma were arbitrarily classified into control group ( n = 48) and intervention group ( n = 48). The control group received only immune checkpoint inhibitors or chemotherapy, while the intervention group received immune checkpoint inhibitors or chemotherapy, plus probiotic therapy. Survival and complication rates after 6 months, 12 months and 2 years of treatment were calculated. Intestinal barrier function, immune function and quality of life were analyzed before and after treatment. Ninety-six patients were recorded at the follow-up demonstrating superior survival in the intervention group after 6 months, 12 months and 2 years of therapy. D-lactate and diamine oxidase (DAO) levels were elevated in the intervention group after treatment, with smaller elevations ( P < 0.05). The levels of Bifidobacterium and Lactobacillus were remarkably higher in the intervention group after treatment compared to the control group prior to and following therapy ( P < 0.05). The amount of Enterococcus and Escherichia coli in the intervention group after treatment was obviously lower compared to the pre-treatment and control groups ( P < 0.05). CD3 + , CD4 + , and CD4 + /CD8 + levels were found to be higher in the intervention group ( P < 0.05), while CD8 + levels were reduced in the intervention group ( P < 0.05). All dimensions of the QLQC-30 scale were higher in the intervention group ( P < 0.05). The incidence of complications such as nausea and vomiting, loss of appetite, bloating and diarrhea was considerably reduced in the intervention group ( P < 0.05). Immune checkpoint suppressors combined with chemotherapeutic agents or probiotic regimens can obviously enhance the prognosis of patients with metastatic colorectal carcinoma. This combination therapeutic strategy can balance the imbalanced intestinal flora, improve intestinal function, and lessen the incidence of adverse events, so it is worthy of clinical application and can lessen the incidence of adverse reactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12876-025-03604-9

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The flow chart of the study
Fig. 1 The flow chart of the studyCC BY-NC-ND · PubMed Central
Fig. 2 The survival rate between the two groups
Fig. 2 The survival rate between the two groupsCC BY-NC-ND · PubMed Central
Fig. 3 comparison of the incidence of complications
Fig. 3 comparison of the incidence of complicationsCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 6

  1. Lin F, Chao L, Chunhui Z, et al. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer. J Pract Oncol. 2019;33(02):173–8.
  2. Enlong W, Sufei Z, Guangran M, et al. Study on the significance of screening for a high-risk population of colorectal cancer in Xingqing District of Yinchuan City. Ningxia Med J. 2018;40(01):58–60.
  3. Zhang C, Yang W. Multivariate analysis of the efficacy and prognosis of adjuvant chemotherapy in elderly patients with colon cancer after radical resection. Electron J Clin Med Lit. 2019;6(43):79–80.
  4. Tang L, Liu B. Research progress of intestinal flora in the pathogenesis and treatment of colorectal cancer. Shandong Med. 2022;62(10):101–4.
  5. Medical Administration of the Health and Family Planning Commission of the people's Republic of China, Oncology Branch of Chinese Medical Association. Chinese norms for diagnosis and treatment of Colorectal Cancer (2017 Edition) [J]. Chin J Surg. 2018;56(04): 241–258.
  6. Zhao X, Jia Jinsheng LQ. Meta analysis of the preventive and therapeutic effect of probiotics on chemotherapy-associated diarrhea. J Pharmacoepidemiol. 2018;27(6):366–73+409.

Cited by

See all 18

Metadata

Authors
Wang, X., Huang, Y., Yang, Z., Yang, Y., Wei, F., Yan, M., Li, F., & Wang, C.
Affiliations
Second Affiliated Hospital of Anhui Medical University (CN)
Corresponding author
Li, Fanfan
Venue
BMC Gastroenterology
Published
2025-01-27
Volume
25
Issue
1
Pages
38-38
ISSN
1471-230X (ISSN-L)
OpenAlex
W4406872434
Cited by
18
References
28
Citations by year
2026: 13 · 2025: 5
FWCI
8.43
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Gastroenterology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
probiotics, metastatic colorectal cancer, immune checkpoint inhibitors, chemotherapy, intestinal immunity, intestinal barrier function, gut microbiota, Bifidobacterium, Lactobacillus, D-lactate, diamine oxidase, CD4/CD8 ratio, quality of life, treatment-related adverse events, survival
MeSH terms
Gastrointestinal Microbiome, Immune Checkpoint Inhibitors, Adult, Aged, Antineoplastic Agents, Female, Amine Oxidase (Copper-Containing), Humans, Male, Middle Aged, Prognosis, Quality of Life, Colorectal Neoplasms, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study. https://app.cochat.ai/papers/10.1186/s12876-025-03604-9
The paper
Wang, X., Huang, Y., Yang, Z., Yang, Y., Wei, F., Yan, M., Li, F., & Wang, C. (2025). Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study. BMC Gastroenterology. https://doi.org/10.1186/s12876-025-03604-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.